![Medical Health News](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/931/normal/Screen_Shot_2018-10-19_at_10.16.53.png?1539940643)
Study Summary: Response and Progression-Free Survival at 18 Months With Lenalidomide and ...
Medical Health News,
Dimopoulos M, Wang M, Maisnar V, et al. Response and progression-free survival according to planned treatment duration in…
Dimopoulos M, Wang M, Maisnar V, et al. Response and progression-free survival according to planned treatment duration in…
Dimopoulos M, Wang M, Maisnar V, et al. Response and progression-free survival according to planned treatment duration in…
April 06, 2018 Patients treated with KRd had a complete response rate of 28.6% (compared with 6.6% for the Rd group) over the…